Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis

NCT00477191 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Difficulty in recruitment.

Conditions

Psoriasis
Metabolic Syndrome
Hyperlipidemia
Obesity
Hypertension

Interventions

DRUG: Etanercept

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]